BC
AGN

Banced Corp’s Allergan plc AGN Stock Holding History

Banced Corp’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-747
Closed -$203K – 132
2016
Q2 		$203K Buy
+747
New +$172K 0.38% 111
2015
Q4 		– Sell
-747
Closed -$203K – 127
2015
Q3 		$203K Sell
747
-401
-35% -$123K 0.37% 113
2015
Q2 		$348K Buy
1,148
+99
+9% +$29.5K 0.47% 87
2015
Q1 		$312K Sell
1,049
-328
-24% -$93.5K 0.44% 97
2014
Q4 		$354K Sell
1,377
-332
-19% -$83K 0.39% 99
2014
Q3 		$412K Sell
1,709
-14
-0.8% -$3.13K 0.48% 81
2014
Q2 		$384K Sell
1,723
-509
-23% -$105K 0.46% 92
2014
Q1 		$459K Sell
2,232
-678
-23% -$134K 0.48% 80
2013
Q4 		$489K Sell
2,910
-241
-8% -$37.7K 0.49% 82
2013
Q3 		$454K Buy
3,151
+579
+23% +$77.1K 0.46% 91
2013
Q2 		$325K Buy
+2,572
New +$291K 0.33% 121

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Banced Corp's AGN Position: Q3 2016 in Review

Banced Corp sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 747 shares — an estimated $203K sold.

Banced Corp first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $489K in Q4 2013. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Banced Corp reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Banced Corp sold 747 Allergan plc shares in Q3 2016, an estimated $203K.
  • Banced Corp first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
  • Banced Corp's Allergan plc position peaked at $489K in Q4 2013.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Banced Corp's 13F filing for Q3 2016, filed 12 Oct 2016.